Clinical Trial Update: D-serine AudRem: R33 Phase [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of D-serine AudRem (R33) for schizophrenia and schizoaffective disorder is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-serine AudRem R33 (D-serine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizo Affective Disorder | Phase 1, Phase 2 | Status: SUSPENDED